Function of dopamine receptors in young-onset Parkinson's disease: prolactin response

Mov Disord. 1993 Apr;8(2):227-9. doi: 10.1002/mds.870080223.

Abstract

The basal levels of prolactin (PRL) and their changes after i.v. thyrotropin releasing hormone (TRH) administration after bromocriptine (BCT) pretreatment (BCT/TRH test) were monitored in 12 patients with young-onset Parkinson's disease (PD) (before 40 years of age) and 10 patients with older-onset PD (after 40 years of age), as well as in two groups of healthy subjects (10 persons in each), age-matched with older-onset (control A) and young-onset (control B) parkinsonians. The basal PRL levels were normal in both groups of patients. When given after BCT, TRH induced a significantly lower PRL increase in older-onset parkinsonians than in controls. This response was even more blunted in young-onset patients, being significantly more attenuated than in older-onset PD patients.

MeSH terms

  • Adult
  • Bromocriptine / therapeutic use
  • Humans
  • Hypothalamo-Hypophyseal System / drug effects
  • Hypothalamo-Hypophyseal System / physiopathology
  • Male
  • Middle Aged
  • Neurologic Examination / drug effects
  • Parkinson Disease / drug therapy
  • Parkinson Disease / physiopathology*
  • Prolactin / blood*
  • Receptors, Dopamine / drug effects
  • Receptors, Dopamine / physiology*
  • Receptors, Dopamine D2 / drug effects
  • Receptors, Dopamine D2 / physiology
  • Thyrotropin-Releasing Hormone

Substances

  • Receptors, Dopamine
  • Receptors, Dopamine D2
  • Bromocriptine
  • Thyrotropin-Releasing Hormone
  • Prolactin